Literature DB >> 2598750

Cyclosporine and inflammatory bowel disease.

D H Van Thiel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2598750     DOI： 10.1007/bf01536697

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  6 in total

Review 1.  Colon cancer, dysplasia, and surveillance in patients with ulcerative colitis. A critical review.

Authors:  R H Collins; M Feldman; J S Fordtran
Journal:  N Engl J Med       Date:  1987-06-25       Impact factor: 91.245

2.  Cyclosporin for Crohn's disease.

Authors:  M C Allison; R E Pounder
Journal:  Lancet       Date:  1984-04-21       Impact factor: 79.321

3.  Development of lymphoma in patients with Crohn disease.

Authors:  S N Glick; S K Teplick; L R Goodman; H R Clearfield; J D Shanser
Journal:  Radiology       Date:  1984-11       Impact factor: 11.105

4.  Cyclosporin A treatment in inflammatory bowel disease.

Authors:  E F Stange; W E Fleig; E Rehklau; H Ditschuneit
Journal:  Dig Dis Sci       Date:  1989-09       Impact factor: 3.199

5.  A comparison of cancer risk in Crohn's disease and ulcerative colitis.

Authors:  A J Greenstein; D B Sachar; H Smith; H D Janowitz; A H Aufses
Journal:  Cancer       Date:  1981-12-15       Impact factor: 6.860

6.  Ulcerative colitis disease activity as subjectively assessed by patient-completed questionnaires following orthotopic liver transplantation for sclerosing cholangitis.

Authors:  J S Gavaler; B Delemos; S H Belle; A E Heyl; R E Tarter; T E Starzl; C Gavaler; D H van Thiel
Journal:  Dig Dis Sci       Date:  1991-03       Impact factor: 3.199
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.